US stocks were mixed as investors prepared for earnings season to pick up steam, with Big Tech earnings ahead.

The U.S. Food and Drug Administration on Friday asked Sarepta to voluntarily halt shipments of the gene therapy, but the company refused to do so and said it would continue making the treatment ...